Entrada Therapeutics Inc. Price to FCF Ratio 2021–2026

PE Ratio PS Ratio Price to Book Price to FCF Net Worth

Price to free cash flow (P/FCF) ratio for Entrada Therapeutics Inc. (TRDA): market cap divided by trailing twelve-month free cash flow. As of September 30, 2024 it is 4.84.

From: 03/31/2023To: 03/31/2026

Stock Price

TTM Free Cash Flow

Price to FCF

Entrada Therapeutics Inc. Price to FCF Ratio — FAQ

Entrada Therapeutics Inc. (TRDA) price to fcf ratio over the last 3 years — annual and quarterly figures with year-over-year growth and charts.

Where can I see TRDA's price to fcf ratio history?

The chart and table above show Entrada Therapeutics Inc.'s price to fcf ratio by year and by quarter, including the growth rate.